TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) Shares Are Down -70.04% Year To Date.

EVTL

In the last trading session, 0.14 million TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) shares changed hands as the company’s beta touched 0.12. With the company’s per share price at $0.95 changed hands at $0.0 or -0.03% during last session, the market valuation stood at $3.04M. TCBP’s last price was a discount, traded about -1963.16% off its 52-week high of $19.60. The share price had its 52-week low at $0.85, which suggests the last value was 10.53% up since then. When we look at TC BioPharm (Holdings) plc ADR’s average trading volume, we note the 3-month average coming to 2.39 million.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) trade information

Instantly TCBP was in red as seen at the end of in last trading. With action -9.54%, the performance over the past five days has been red. The drop to weekly highs of 1.1300 subtracted -0.03% to the stock’s daily price. The company’s shares are showing year-to-date downside of -70.04%, with the 5-day performance at -9.54% in the red. However, in the 30-day time frame, TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) is -15.95% down.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

TC BioPharm (Holdings) plc ADR (TCBP) estimates and forecasts

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 45.82%.

TCBP Dividends

TC BioPharm (Holdings) plc ADR is expected to release its next quarterly earnings report in July.